| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 682 shares
@ $2.36, valued at
$1.6k
Exercised 2,292 options to buy
@ $0.511, valued at
$1.2k
|
|
| 07/12/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 687 shares
@ $2.34, valued at
$1.6k
Exercised 2,292 options to buy
@ $0.511, valued at
$1.2k
|
|
| 06/30/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 03/15/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 892 shares
@ $1.7532, valued at
$1.6k
Exercised 2,291 options to buy
@ $0.511, valued at
$1.2k
|
|
| 03/08/2023 |
4
| Simon Farrell (Chief Commercial Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Exercised 18,750 options to buy
@ $0.511, valued at
$9.6k
|
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
3
| Clark David J (Chief Medical Officer) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 09/19/2022 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $3.21, valued at
$24.1k
|
|
| 09/19/2022 |
4
| GOOD JENNIFER L (President & CEO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $3.21, valued at
$102.7k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4/A
| Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.27, valued at
$45.4k
|
|
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.27, valued at
$45.4k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.27, valued at
$45.4k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|